Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
kolagen-pharma.com

See what CB Insights has to offer

Stage

Series A | Alive

Total Raised

$460K

About Kola-Gen Pharma Co. Ltd.

Developer of drugs using artificial collagen polypeptide. The company is engaged in the research and development of regenerative medicine and biomedical research reagent using synthetic collagen polypeptide. It also develops medical equipment.

Kola-Gen Pharma Co. Ltd. Headquarter Location

KU Katsura Venture Plaza South, 2104 1-39 Goryoohara, Nishikyo-ku

Kyoto, 615-8245,

Japan

81 75 391 5595

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Kola-Gen Pharma Co. Ltd.

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Kola-Gen Pharma Co. Ltd. is included in 2 Expert Collections, including Regenerative Medicine.

R

Regenerative Medicine

1,708 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

B

Biopharmaceuticals

5,726 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Kola-Gen Pharma Co. Ltd. Patents

Kola-Gen Pharma Co. Ltd. has filed 1 patent.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Collagens
  • Dosage forms
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/23/2016

12/1/2020

Clusters of differentiation, Dosage forms, Collagens, Drug delivery devices, Glycoproteins

Grant

Application Date

6/23/2016

Grant Date

12/1/2020

Title

Related Topics

Clusters of differentiation, Dosage forms, Collagens, Drug delivery devices, Glycoproteins

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.